Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-05-19 Purchase(A) |
2022-05-23 4:00 pm |
Gain Therapeutics Inc. | GANX | Calabrese Salvatore CHIEF FINANCIAL OFFICER |
3,000 | $2.7 | $8,100 | 3,000 (Direct) |
View |
| 2022-05-19 Purchase(M) |
2022-05-19 5:00 pm |
Gain Therapeutics Inc. | GANX | Calabrese Salvatore CHIEF FINANCIAL OFFICER |
3,000 | $2.7 | $8,100 | 8,100 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-03-23 Option Award |
2023-03-27 5:28 pm |
N/A 2033-03-23 |
Gain Therapeutics Inc. | GANX | Calabrese Salvatore Chief Financial Officer |
75,000 | $0 | 75,000 (Direct) |
View |
| 2022-07-15 Option Award |
2022-07-19 4:37 pm |
N/A 2032-07-15 |
Gain Therapeutics Inc. | GANX | Calabrese Salvatore Chief Financial Officer |
69,300 | $0 | 69,300 (Direct) |
View |
Ownership |
2021-03-29 8:34 pm |
N/A 2030-09-24 |
Gain Therapeutics Inc. | GANX | Calabrese Salvatore Chief Financial Officer |
0 | $0 | 83,674 (Direct) |
View |